Atlas Trials

Nanjing Yoko Biomedical Co., Ltd.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Nanjing Yoko Biomedical Co., Ltd.

RecordFirmDate
A Clinical Study of YK-1169 Versus Ceftazidime-Avibactam in Adults With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (NCT07634198)Nanjing Yoko Biomedical Co., Ltd.2026-06-04
Study on Tolerance, Pharmacokinetics and Drug Interaction of YK-1169 in Healthy Volunteers (NCT05588531)Nanjing Yoko Biomedical Co., Ltd.2021-12-20
Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke (NCT04984577)Nanjing Yoko Biomedical Co., Ltd.2021-11-15
Safety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive Emergencies (NCT04670809)Nanjing Yoko Biomedical Co., Ltd.2020-07-27
Study on Clinical Effectiveness of L-Oxiracetam Injection (NCT04205565)Nanjing Yoko Biomedical Co., Ltd.2019-09-30
Safety, Tolerance and Pharmacokinetics Study of Compound Edaravone Injection (NCT04219865)Nanjing Yoko Biomedical Co., Ltd.2019-06-05
Drug-drug Interaction Study Between Edaravone and 2-Aminoethanesulfonic Acid in Compound Edaravone Injection (NCT04218513)Nanjing Yoko Biomedical Co., Ltd.2019-05-10
A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients (NCT03650933)Nanjing Yoko Biomedical Co., Ltd.2018-12-28

Track Nanjing Yoko Biomedical Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.